CC:NYE-Chemours Company (The)

EQUITY | Chemicals | New York Stock Exchange

Last Closing

USD 39.39

Change

+0.37 (+0.95)%

Market Cap

USD 4.28B

Volume

1.63M

Analyst Target

USD 44.92
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Chemours Co is engaged in developing and manufacturing titanium technologies, fluoroproducts and chemical solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-03-19 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
SHECF Shin-Etsu Chemical Co. Ltd

-0.27 (-0.60%)

USD 90.44B
DOW Dow Inc

-0.21 (-0.36%)

USD 39.17B
CE Celanese Corporation

+2.22 (+1.31%)

USD 16.71B
TYNPF Nippon Sanso Holdings Corporat..

-0.95 (-2.91%)

USD 14.16B
AHKSF Asahi Kasei Corporation

N/A

USD 10.43B
HUN Huntsman Corporation

+0.13 (+0.50%)

USD 4.35B
BAK Braskem SA Class A

-0.37 (-3.39%)

USD 4.19B
SOMMF Sumitomo Chemical Company Limi..

+0.05 (+2.27%)

USD 3.67B
TROX Tronox Holdings PLC

-0.36 (-2.03%)

USD 2.53B
WLKP Westlake Chemical Partners LP

-0.03 (-0.13%)

USD 0.80B

ETFs Containing CC

HTWO:SW L&G Hydrogen Economy UCIT.. 5.69 % 0.00 %

+0.01 (+-0.75%)

USD 0.43B
HTMW:F L&G Hydrogen Economy UCIT.. 5.69 % 0.00 %

-0.03 (-0.75%)

USD 0.43B
HTWG:LSE L&G Hydrogen Economy UCIT.. 5.59 % 0.00 %

-1.10 (-0.75%)

USD 0.42B
HTWO:LSE L&G Hydrogen Economy UCIT.. 5.59 % 0.00 %

+0.01 (+-0.75%)

USD 0.42B
EQLT 0.00 % 0.75 %

N/A

N/A
SMD 0.00 % 0.10 %

N/A

N/A
YXM.A:CA 0.00 % 1.49 %

N/A

N/A
YXM.D:CA 0.00 % 1.53 %

N/A

N/A
DESD:LSE 0.00 % 0.00 %

N/A

N/A
DESE:LSE 0.00 % 0.00 %

N/A

N/A
WTEC:F 0.00 % 0.00 %

N/A

N/A
WTEC:XETRA 0.00 % 0.00 %

N/A

N/A
HTMW:XETRA L&G Hydrogen Economy UCIT.. 0.00 % 0.00 %

+0.01 (+-0.75%)

USD 0.43B

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.58% 91% A- 95% A
Dividend Return 0.89% 73% C 47% F
Total Return 40.47% 91% A- 95% A
Trailing 12 Months  
Capital Gain -20.31% 36% F 15% F
Dividend Return 1.86% 49% F 33% F
Total Return -18.45% 36% F 15% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 108.97% 100% F 99% N/A
Dividend Return 110.03% 100% F 99% N/A
Total Return 1.06% 13% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 173.46% 2% F 1% F
Risk Adjusted Return 63.43% 74% C 67% D+
Market Capitalization 4.28B 73% C 83% B

Key Financial Ratios

  Ratio vs. Industry/Classification (Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 28.70 87% 66%
Price/Book Ratio 5.90 29% 12%
Price / Cash Flow Ratio 1.57 78% 67%
Price/Free Cash Flow Ratio 10.73 64% 51%
Management Effectiveness  
Return on Equity 95.44% 96% 97%
Return on Invested Capital 24.38% 85% 88%
Return on Assets 13.40% 96% 93%
Debt to Equity Ratio 387.50% 15% 6%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector